RegenMD - Medtronic buys a stake in regenerative medicine firm

RegenMD         Medtronic buys a stake in regenerative medicine firm April 15, 2011 at 9:09 PM   Medtronic has invested $7 million in a Pennsylvania-based regenerative medicine company, gaining a 17 percent stake in the company. The agreement also puts Fridley-based Medtronic first in line to buy a key technology Tengion is working on. ... See all stories on this topic »         Shrink Nanotechnologies Announces That Critical Cell Align Tissue ... April 15, 2011 at 6:04 PM   In the United States, tissue engineering and cell therapy comprised a $6.9 billion market for regenerative products in 2009, and is expected to approach $32 ...         California Stem Cell Report Cited as One of 25 Best Stem Cell Blogs April 15, 2011 at 11:36 AM         Stem cell researchers to link up with US April 15, 2011 at 10:42 AM   "It was a morale boost for Australian scientists hearing negatives about funding," says Australian medical researcher Alan Trounson, president of the California Institute for Regenerative Medicine in San Francisco. "If you get the best scientists ... See all stories on this topic »         Medtronic eyes regenerative medicine market with Tengion investment April 15, 2011 at 9:13 AM   based company is developing a pipeline of cell- and tissue-based regenerative medicine treatments. Tengion first went public almost exactly a year ago, but its stock failed to gain traction until early this year, forcing it to seek more backing ... See all stories on this topic »             This email was sent to agupta1213+termsc@gmail.com. Delivered by Feed My Inbox PO Box 682532 Franklin, TN 37068 Account Login Unsubscribe Here